PreDxion Bio Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 3
Employees
  • Latest Deal Type
  • Seed
  • Latest Deal Amount
  • $7.7M
Latest Deal Amount
  • Investors
  • 12

PreDxion Bio General Information

Description

Developer of a scalable sensor platform designed to detect viruses and proteins, with an acute focus on addressing SARS-CoV-2 pandemic. The company has developed localized surface plasmon resonance (LSPR) biosensor technology, low-cost reader HW, and its relating application, enabling physicians to precisely treat patients within time and end the global SARS-CoV-2 pandemic.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Other Healthcare Services
Decision/Risk Analysis
Primary Office
  • 329 Oyster Point Boulevard
  • Floor 3
  • San Francisco, CA 94080
  • United States
+1 (734) 000-0000

PreDxion Bio Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PreDxion Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Seed Round 18-Sep-2020 $7.7M 00.000 000.00 Completed Product In Beta Test
5. Grant 01-Jan-2018 00000 00000 Completed Product In Beta Test
4. Accelerator/Incubator 22-Aug-2017 00000 00000 00.000 Completed Startup
3. Accelerator/Incubator 10-Jul-2017 Completed Startup
2. Accelerator/Incubator 21-Jun-2016 Completed Startup
1. Grant 16-Apr-2016 $130K Completed Startup
To view PreDxion Bio’s complete valuation and funding history, request access »

PreDxion Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 4 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed 3 000,000 00.000000 00 00.00 00.00 00 00.00 0.000
Seed 2 00,000 00.000000 00 00.00 00.00 00 00.00 0.00
Seed 1 148,522 $0.000100 8% $0.67 $0.67 1x $0.67 0.81%
Seed 5,921,156 $0.000100 8% $1.24 $1.24 1x $1.24 32.12%
To view PreDxion Bio’s complete cap table history, request access »

PreDxion Bio Executive Team (3)

Name Title Board Seat Contact Info
Walker McHugh Co-Founder, President, Chief Executive Officer & Board Member
Caroline Landau Co-Founder & Head of Operations
Timothy Cornell Co-Founder, Chief Scientific Advisor & Board Member
To view PreDxion Bio’s complete executive team members history, request access »

PreDxion Bio Board Members (2)

Name Representing Role Since
Timothy Cornell PreDxion Bio Co-Founder, Chief Scientific Advisor & Board Member 000 0000
Walker McHugh PreDxion Bio Co-Founder, President, Chief Executive Officer & Board Member 000 0000
To view PreDxion Bio’s complete board members history, request access »

PreDxion Bio Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PreDxion Bio Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Houston Angel Network Angel Group 000 0000 000000 0
Invest Detroit Ventures Corporate Venture Capital Minority 000 0000 000000 0
National Institutes of Health Government Minority 000 0000 000000 0
Paul Buchheit Angel (individual) Minority 000 0000 000000 0
SignalFire Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 12 investors. Get the full list »